dendritic cell vaccine therapy

BIOLOGICAL4 trials

Sponsors

Jonsson Comprehensive Cancer Center, Mayo Clinic

Conditions

Adult Diffuse Mixed Cell LymphomaAdult Diffuse Small Cleaved Cell LymphomaAdult Grade III Lymphomatoid GranulomatosisAdult Immunoblastic Large Cell LymphomaAdult Lymphoblastic LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueGrade 1 Follicular Lymphoma

Early Phase 1

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

CompletedNCT01239875

Mayo ClinicAdult Diffuse Mixed Cell Lymphoma, Adult Diffuse Small Cleaved Cell Lymphoma, Adult Grade III Lymphomatoid Granulomatosis +13

Start: 2010-11-30End: 2019-07-17Updated: 2020-01-14

Phase 1

Vaccine Therapy in Treating Patients With Advanced Kidney Cancer

CompletedNCT00004880

Jonsson Comprehensive Cancer CenterKidney Cancer

Start: 1997-06-30Updated: 2020-08-03

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

TerminatedNCT02070406

Jonsson Comprehensive Cancer CenterUnspecified Adult Solid Tumor, Protocol Specific

Start: 2014-07-17End: 2018-12-18Updated: 2019-02-28

Phase 2

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Active, not recruitingNCT01697527

Jonsson Comprehensive Cancer CenterMalignant Neoplasm

Start: 2012-11-02End: 2027-11-02Updated: 2025-11-24

Related Papers

Abstract 914: Preinfusion polyfunctional profiles and cytokine secretion activity of transgenic TCR-T cells, and serum cytokine profiles, are associated with clinical outcomes in sarcoma and melanoma

Cancer Research2023-04-04

A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab

Clinical Cancer Research2018-12-2091 citations

Abstract CT008: A pilot trial of the combination of transgenic NY-ESO-1-reactive adoptive cellular therapy with dendritic cell vaccination with or without ipilimumab in patients with sarcoma and melanoma

Cancer Research2018-07-013 citations

Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress

Journal for ImmunoTherapy of Cancer2014-11-06